Unexplained weight loss (UWL), defined as a loss of more than 5% of body weight over a period of 6 to 12 months without a clear etiology, poses a significant diagnostic challenge for clinicians. This article aims to provide a comprehensive guide to help clinicians methodically approach this issue and optimize patient care.
Firstly, a detailed patient history is paramount. This should include dietary habits, physical activity, social circumstances, and medication use. A comprehensive physical examination can reveal signs of malnutrition, malignancy, endocrine disorders, or gastrointestinal diseases. These findings can guide further investigations.
Initial laboratory investigations should include a complete blood count, liver and kidney function tests, electrolyte levels, thyroid function tests, and tests for diabetes. Imaging studies, such as CT scans or ultrasounds, can be helpful in identifying occult malignancies or other systemic diseases. If these tests are inconclusive, more specific investigations may be warranted based on the patient's history and physical examination.
It's important to consider age-related factors. In older adults, UWL may be a sign of malignancy, while in younger patients, it may suggest psychiatric conditions like depression or eating disorders. Additionally, UWL could be a symptom of a chronic infection such as HIV or tuberculosis, especially in high-risk populations.
If the cause of UWL remains elusive after thorough evaluation, referral to a specialist, such as a gastroenterologist, endocrinologist, or psychiatrist, may be necessary. These specialists can offer further diagnostic tests and management options.
Unexplained weight loss is a complex clinical problem that requires a systematic and comprehensive approach. A thorough history, physical examination, and appropriate investigations can often identify the underlying cause. In cases where the cause remains unclear, referral to a specialist is recommended. By adopting this comprehensive approach, clinicians can ensure optimal patient care and management.
1.
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma
2.
In patients with prostate cancer, second-generation antiandrogens may worsen fatigue, falls, and cognitive decline.
3.
Infection tied to one-fourth of deaths with lower-risk myelodysplastic syndromes
4.
Booze and Pancreatic Cancer Risk; From 'Hospice' to 'Hope'; Gen Z-ers Skip Screening
5.
Cancer screening rates down among American adults
1.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
2.
The Pros and Cons of Using Cyclophosphamide in Cancer Treatment
3.
A Comprehensive Guide to Living with Cutaneous T Cell Lymphoma: Tips & Strategies
4.
The Truth About Marijuana and Its Effect on Mental Health
5.
Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
2.
From Guidelines to Practice: Hematology
3.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
5.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation